Geode Capital Management, LLC Akero Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,619,039 shares of AKRO stock, worth $44.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,619,039

Previous 1,419,307 14.07%

Holding current value

$44.8 Million

Previous $35.9 Million 5.94%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$18.31 - $24.62 $3.66 Million - $4.92 Million	199,732 Added 14.07%	1,619,039 $38 Million
Q1 2024 May 13, 2024	BUY	$17.76 - $31.18 $4.49 Million - $7.89 Million	253,062 Added 21.7%	1,419,307 $35.9 Million
Q4 2023 Feb 13, 2024	BUY	$11.38 - $50.33 $716,245 - $3.17 Million	62,939 Added 5.7%	1,166,245 $27.2 Million
Q3 2023 Nov 13, 2023	BUY	$41.19 - $52.25 $11.5 Million - $14.6 Million	278,599 Added 33.78%	1,103,306 $55.8 Million
Q2 2023 Aug 11, 2023	BUY	$36.89 - $56.88 $5.86 Million - $9.03 Million	158,780 Added 23.84%	824,707 $38.5 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $50.24 $1.21 Million - $1.64 Million	32,547 Added 5.14%	665,927 $25.5 Million
Q4 2022 Feb 13, 2023	BUY	$33.44 - $54.8 $3.68 Million - $6.03 Million	110,091 Added 21.04%	633,380 $34.7 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $561,335 - $1.88 Million	55,304 Added 11.82%	523,289 $17.8 Million
Q2 2022 Aug 12, 2022	BUY	$8.0 - $15.01 $196,096 - $367,925	24,512 Added 5.53%	467,985 $4.42 Million
Q1 2022 May 13, 2022	BUY	$12.97 - $22.26 $347,492 - $596,389	26,792 Added 6.43%	443,473 $6.29 Million
Q4 2021 Feb 11, 2022	BUY	$19.87 - $26.24 $774,691 - $1.02 Million	38,988 Added 10.32%	416,681 $8.81 Million
Q3 2021 Nov 12, 2021	BUY	$18.65 - $25.46 $281,894 - $384,827	15,115 Added 4.17%	377,693 $8.44 Million
Q2 2021 Aug 13, 2021	BUY	$24.81 - $32.35 $2.43 Million - $3.17 Million	98,095 Added 37.09%	362,578 $9 Million
Q1 2021 May 12, 2021	BUY	$24.04 - $34.19 $548,616 - $780,249	22,821 Added 9.44%	264,483 $7.67 Million
Q4 2020 Feb 12, 2021	BUY	$25.12 - $29.89 $195,735 - $232,902	7,792 Added 3.33%	241,662 $6.23 Million
Q3 2020 Nov 13, 2020	BUY	$30.79 - $39.92 $2.89 Million - $3.75 Million	93,903 Added 67.09%	233,870 $7.2 Million
Q2 2020 Aug 13, 2020	BUY	$19.25 - $26.76 $501,655 - $697,365	26,060 Added 22.88%	139,967 $3.49 Million
Q1 2020 May 14, 2020	BUY	$12.8 - $27.05 $443,686 - $937,634	34,663 Added 43.74%	113,907 $2.41 Million
Q4 2019 Feb 13, 2020	BUY	$17.37 - $27.27 $81,864 - $128,523	4,713 Added 6.32%	79,244 $1.76 Million
Q3 2019 Nov 12, 2019	BUY	$16.89 - $29.88 $1.26 Million - $2.23 Million	74,531 New	74,531 $1.7 Million

Others Institutions Holding AKRO

# of Institutions

168

Shares Held

72.7M

Call Options Held

178K

Put Options Held

164K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.28B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Akero Therapeutics, Inc. Transaction History